GENESIS Trademark

Trademark Overview

On Wednesday, February 16, 2011, a trademark application was filed for GENESIS with the United States Patent and Trademark Office. The USPTO has given the GENESIS trademark a serial number of 85243514. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, May 27, 2020. This trademark is owned by Genesis Biotechnology Group, LLC. The GENESIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields, specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding body donation research
genesis

General Information

Serial Number85243514
Word MarkGENESIS
Filing DateWednesday, February 16, 2011
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, May 27, 2020
Registration Number4659839
Registration DateTuesday, December 23, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 21, 2014

Trademark Statements

Description of MarkThe mark consists of the stylized term "GENESIS" with a stylized depiction of a molecule consisting of fourteen spheres representing atoms that are connected by straight bands representing bonds wherein the letter "I" in "GENESIS" is represented by a vertical band connecting two atoms; the color maroon appears in the letters "GENES" and "S" in "GENESIS"; the color beige appears in the fourteen spheres representing atoms; the color black appears in the letter "I" in "GENESIS" and in the straight lines representing bonds; the color white appears in the shading of the atoms.
Indication of Colors claimedThe color(s) maroon, beige, black and white is/are claimed as a feature of the mark.
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields, specifically relating to molecular diagnostics, such as, Polymerase Chain Reactions, cancer research, such as, cervical, bladder and prostate cancers, women's health research, such as, bacterial vaginosis, herpes simplex virus, human papillomavirus, and gonorrhea, biomarker and novel drug discovery, such as, high throughput screening of new chemical compounds, immunology abnormality, such as, irritable bowel disease and Crohn's disease, antimicrobials research, all of the foregoing goods and services excluding body donation research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 22, 2011
Primary Code042
First Use Anywhere DateSunday, January 31, 2010
First Use In Commerce DateSunday, January 31, 2010

Trademark Owner History

Party NameGenesis Biotechnology Group, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690
Party NameGenesis Biotechnology Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690
Party NameGenesis Biotechnology Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHamilton, NJ 08690

Trademark Events

Event DateEvent Description
Saturday, December 23, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, September 15, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 27, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, May 27, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 26, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 31, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, December 23, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 23, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, November 20, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 19, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 3, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 9, 2014USE AMENDMENT FILED
Monday, November 3, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 9, 2014TEAS STATEMENT OF USE RECEIVED
Saturday, September 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 18, 2014SOU EXTENSION 1 GRANTED
Thursday, September 18, 2014SOU EXTENSION 1 FILED
Thursday, September 18, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, March 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 19, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 17, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 14, 2013JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, September 3, 2013NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, September 3, 2013SUBSEQUENT FINAL EMAILED
Tuesday, September 3, 2013SUBSEQUENT FINAL REFUSAL WRITTEN
Wednesday, August 7, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 7, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 7, 2013NON-FINAL ACTION E-MAILED
Thursday, February 7, 2013NON-FINAL ACTION WRITTEN
Friday, January 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 25, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 24, 2013ASSIGNED TO LIE
Tuesday, January 22, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 22, 2013EX PARTE APPEAL-INSTITUTED
Tuesday, January 22, 2013JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, January 22, 2013EXPARTE APPEAL RECEIVED AT TTAB
Sunday, July 22, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, July 22, 2012FINAL REFUSAL E-MAILED
Sunday, July 22, 2012FINAL REFUSAL WRITTEN
Thursday, June 7, 2012SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, June 7, 2012ASSIGNED TO LIE
Wednesday, December 7, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 7, 2011LETTER OF SUSPENSION E-MAILED
Wednesday, December 7, 2011SUSPENSION LETTER WRITTEN
Wednesday, November 23, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 23, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 23, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 23, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 23, 2011NON-FINAL ACTION E-MAILED
Monday, May 23, 2011NON-FINAL ACTION WRITTEN
Wednesday, May 18, 2011ASSIGNED TO EXAMINER
Wednesday, February 23, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, February 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 19, 2011NEW APPLICATION ENTERED

Related Keywords

genesis research such disease screening chemical compounds throughput discovery biomarker gonorrhea